from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1995/-

LFCtreatmentdescriptionclass of inhibitor

-0.286

Amikacinug/mL Amikacintranslation

-0.010

Cap5-10ug/mL Capreomycintranslation

0.212

Rox10-50 ug/mL Roxithromycintranslation

-0.344

SM2-5 ug/mL Streptomycintranslation

0.346

Tet5-10 ug/mL Tetracyclinetranslation

-0.023

Rif0.2-5ug/mL Rifampicintranscription

-0.598

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.183

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.151

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.388

CPZ10-50 ug/mL Chlorpromazinerespiration

4.170

Clofazimine10-13 ug/mL Clofaziminerespiration

0.003

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.692

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.104

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.480

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.263

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.399

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.200

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.662

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.322

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.015

Nigericin50 uM Nigericinrespiration

0.056

TRC10-150 ug/mL Triclosanrespiration

1.294

TRZ10-25 ug/mL Thioridazinerespiration

0.491

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.772

menadione6-10 ug/mL Menadionerespiration

1.770

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.351

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.366

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.084

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.133

NRP_1Non-replicating persistence stage 1dosRassociated

-0.711

Amp0.2mg/mL AmpicillincellWall

-0.554

Cephalexin20-100 ug/mL CephalexincellWall

-0.077

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.132

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.498

EMB10-20 ug/mL EthambutolcellWall

0.011

Eta12-40 ug/mL EthionamidecellWall

-0.583

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.303

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.393

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.672

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.044

BZA0.12 mg/mL BenzamidearomaticAmides

-0.126

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.187

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.032

H2O24 mM hydrogen peroxideDNAdamaging

-0.368

Levo10 ug/mL LevofloxacinDNAdamaging

-0.526

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.404

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.332

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.435

UVUV-irradiationDNAdamaging

2.311

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.584

Antimycin12.5-50 ug/mL Antimycin A?

-0.761

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.592

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.563

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.514

PA8240.2-2 ug/mL PA-824?

-0.203

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.651

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.789

Verapamil50 uM Verapamil?

-0.510

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.740

methoxatin10-20 ug/mL Methoxatin?